Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-027916
Filing Date
2018-05-03
Accepted
2018-05-03 20:17:43
Documents
2
Period of Report
2018-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1581
2 POA DOCUMENT poa.txt EX-24.3_786783 3541
  Complete submission text file 0001209191-18-027916.txt   6438
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
McDowell Caryn Gordon (Reporting) CIK: 0001674232 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36297 | Film No.: 18805758